(Created page with "{{Medical Device |Health Topic=Type II Diabetes, |Classification=Diagnosis |Scope=Commercialized |Location=Africa, Asia, Australia, Europe, North America, South America |Image=U...") |
m (re-saving to fix a problem with semantic mediawiki) |
||
| Line 1: | Line 1: | ||
{{Medical Device | {{Medical Device | ||
|Health Topic=Type II Diabetes | |Health Topic=Type II Diabetes | ||
|Classification=Diagnosis | |Classification=Diagnosis | ||
|Scope=Commercialized | |Scope=Commercialized | ||
Revision as of 21:05, 19 November 2013
Problem being addressed
People with diabetes and hypertension are at risk for developing microalbuminuria which is a condition defined by an abnormally high level of the albumin protein in urine (between 30 to 300 mg/day). In a healthy person, the presence of albumin is rarely found in the urine (less than 30 mg/day) because it is normally retained in the bloodstream by the kidneys. Albuminuria could lead to diabetic nephropathy, damaging the nerves in the body due to high blood sugar levels, as well as cause cardiac complications. To prevent vascular damage, constant monitoring is necessary to check for microalbuminaruia.
Detailed description of the solution
This device makes it possible to test for microalbuminuria in urine samples. The strip tests give a reading of the Billirubin, Urobiligen, Ketone, Protein, Nitrite, Glucose, PH, Specific Gravity, Leucocytes, and Mircoalbumin levels which helps with early diagnosis and treatment to prevent damage from diabetic neuropathy.
Designed by
- Manufacturer: This device is commercially distributed and used around the globe.
References
Peer-reviewed publication
McCulloch, DK. Bakris GL et al. (February 29, 2012). Microalbuminuria in type 2 diabetes mellitus. UpToDate.com Retrieved from here.
Viswanathan V, Nair MB, Suresh S, Chamukuttan S, Ambady R. An inexpensive method to diagnose incipient diabetic nephropathy in developing countries. Diabetes Care. 2005;28(5):1259-1260.